CompoAtlas

Thompson's Homeopathic Supplies Ltd. Graphites liquid

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Graphite6 C

Non-medicinal ingredients

Alcool

PopulationAgeQuantity per servingFrequency
AdultesNot specified10 Goutte(s)minimum: 2 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Homeopathic medicine

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Thompson's Homeopathic Supplies Ltd.
NPN or DIN-HM
00761524
Status
Active licence
Licence date
14 September 2009
Revision date
Not provided
Form
Liquide
Route of administration
Sublinguale
Application type
Homéopathique

Source

Official Health Canada record, licence 00761524

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Thompson's Homeopathic Supplies Ltd. Graphites liquid”, https://compoatlas.com/en/supplements/canada/00761524-thompson-s-homeopathic-supplies-ltd-graphites-liquid, updated 14 September 2009.

Enter to analyse, Shift+Enter for a new line